| 中文名 | 4-(环丙烷羰基)哌嗪-1-羧酸叔丁酯 |
|---|---|
| 英文名 | tert-butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate |
| 中文别名 |
奥拉帕尼28
4-环丙烷甲酰基哌嗪-1-羧酸叔丁酯 奥拉帕利杂质9 N-BOC-4-环丙甲酰基哌嗪 奥拉帕尼杂质Z 奥拉帕利杂质Z 4-(环丙烷羰基)哌嗪-1-羧酸叔丁酯(奥拉帕利杂质) 奥拉帕利杂质21 奧拉帕利 杂质 9 奥拉帕利SM3-Z1对照品 (4-BOC-1-哌嗪基)(环丙基)甲酮 奥拉帕尼21 4-环丙甲酰基-哌嗪-1-羧酸叔丁酯 |
| 英文别名 |
Olapali impurity 21
ert-butyl4-(cyclopropanecbonyl)piperazine-1-cboxylate (4-Boc-1-piperazinyl)(cyclopropyl)methanone 4-(cyclopropylcbonyl)-1-Piperazinecboxylic acid 1,1-dimethylethyl ester tert-Butyl 4-(cyclopropanecbonyl)piperazine-1-cboxylate (Olapib Impurity) tert-butyl 4-(cyclopropylcbonyl)-1-piperazinecboxylate tert-butyl 4-(cyclopropylcarbonyl)-1-piperazinecarboxylate 4-cyclopropanoyl-piperazine-1-carboxylic acid tert-butyl ester 1,1-Dimethylethyl 4-(cyclopropylcbonyl)-1-piperazinecboxylate 1-Piperazinecboxylic acid, 4-(cyclopropylcbonyl)-, 1,1-dimethylethyl ester 4-Cyclopropanoylpiperazine-1-cboxylic acid tert-butyl ester tert-butyl 4-(cyclopropanecbonyl)piperazine-1-cboxylate tert-Butyl 4-(cyclopropanecbonyl) Olapib Impurity Z Olapali impurity 9 temether Impurity 13 |
| 沸点 | 388.4°C at 760 mmHg |
|---|---|
| 分子式 | C13H22N2O3 |
| 分子量 | 254.32500 |
| 精确质量 | 254.16300 |
| PSA | 49.85000 |
| LogP | 1.35150 |
| 储存条件 | 室温,干燥密封 |
| 海关编码 | 2933599090 |
|---|
|
~73%
414910-15-9 |
| 文献:BIOMARIN PHARMACEUTICAL INC.; WANG, Bing; CHU, Daniel Patent: WO2011/130661 A1, 2011 ; Location in patent: Page/Page column 102 ; |
|
~%
414910-15-9 |
| 文献:Giannini, Giuseppe; Battistuzzi, Gianfranco; Vesci, Loredana; Milazzo, Ferdinando M.; De Paolis, Francesca; Barbarino, Marcella; Guglielmi, Mario Berardino; Carollo, Valeria; Gallo, Grazia; Artali, Roberto; Dallavalle, Sabrina Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 2 p. 462 - 466 |
| 上游产品 3 | |
|---|---|
| 下游产品 2 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |